- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02370147
Very Brief Smoking Reduction Intervention
February 23, 2015 updated by: Yao He, Chinese PLA General Hospital
The Effect of Very Brief Smoking Reduction Intervention in Smokers Who Having no Intention to Quit: Study Protocol for a Randomized Controlled Trial
A two-arm randomized controlled trial for smokers who are not intent to quit smoking will be proposed in outpatient department clinics of People's Liberation Army General Hospital in Beijing, China.
Smoking reduction intervention arm (SRI) consisting of a very brief face-to-face individual smoking reduction intervention lasted about one minute, and five follow-up interventions lasted for about minute each.
Control arm (EDA) consisting of a very brief face-to-face individual exercise and dietetic advices lasted for the same intervention time as SRI, and also five follow-up interventions lasted for one minute each with different intervention contents.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
500
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged ≥18 years old;
- Smoked more than 10 cigarettes per day in the past month.
- Have no intent to smoking cessation now.
- Agreed to participate in the follow-up, offer telephone number and signed an informed consent form.
Exclusion Criteria:
- Smoked less than 10 cigarettes per day in the past month.
- Had some diseases that let the physician think that it would be unethical not to advise him to quit smoking as soon as possible.
- Cognitively impaired (such as those with deafness or who could not understand and complete the questionnaire reliably).
- Pregnant females.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smoking reduction intervention arm
Smoking reduction intervention arm (SRI) consisting of a minimal face-to-face individual smoking reduction intervention lasted for about one minute, and five follow-up interventions lasted for about one minute each.
|
Smokers was informed that many harmful effects were proved to be related with smoking, such as cancer, coronary heart disease, respiratory disease and many other health problems, and one out of two smokers will be killed by smoking.
Smokers will be advised to reduce smoking consumption for at least half of their total consumption in the next month.
Finally, all smokers were warned to keep in mind that the current attempt to reduce smoking is an intermediate step before the complete cessation.
|
Active Comparator: Control arm
Control arm (UC) consisting of a brief face-to-face individual exercise and dietetic advices lasted for the same intervention time as SRI, and five follow-up interventions lasted for about one minute each with different intervention contents.
|
Smokers will be asked to do regular activities for three or four times per week, and to have a healthy and balanced diet, having more fruit and vegetables which are rich in vitamins, high in nutrition yet low in calories.
In the whole process, advises will not refer to smoking cessation or smoking reduction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
self-reported 7-day point prevalence quit rate
Time Frame: at 12 months follow-up
|
at 12 months follow-up
|
prolonged abstinence quit rate
Time Frame: at 12 months follow-up
|
at 12 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
smoking reduction rates
Time Frame: baseline and at 12 months follow-up
|
number of cigarettes smoked per day reduced at least 50%
|
baseline and at 12 months follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Anticipated)
December 1, 2016
Study Completion (Anticipated)
June 1, 2017
Study Registration Dates
First Submitted
February 10, 2015
First Submitted That Met QC Criteria
February 23, 2015
First Posted (Estimate)
February 24, 2015
Study Record Updates
Last Update Posted (Estimate)
February 24, 2015
Last Update Submitted That Met QC Criteria
February 23, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ChinaPLAGHW
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)TerminatedSmoking | Smoking CessationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
University of MiamiUniversity of MinnesotaCompletedSmoking | Smoking CessationUnited States
Clinical Trials on Smoking reduction intervention
-
University Medicine GreifswaldUnknownTobacco Smoking
-
The University of Hong KongNot yet recruiting
-
National Institutes of Health (NIH)CompletedNicotine Dependence | Cardiac Disease | Tobacco DependenceUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
Hospital Authority, Hong KongThe University of Hong KongCompleted
-
University of RochesterHalcyon Hill FoundationCompleted
-
Ludwig-Maximilians - University of MunichCompleted
-
Florida State UniversityCompleted
-
University of PennsylvaniaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHuman Immunodeficiency Virus (HIV) | Sexually Transmitted Disease (STD)United States
-
Medical University of South CarolinaNational Cancer Institute (NCI)Not yet recruitingSmoking Cessation | Cancer